Alerts will be sent to your verified email
Verify Email
AARTIPHARM
|
Aarti Pharmalabs
|
Shilpa Medicare
|
Supriya Lifescience
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.05 % | 5.0 % | 29.47 % |
|
5yr Avg Net Profit Margin
|
8.95 % | 7.72 % | 24.83 % |
|
Price to Book
|
3.9 | 3.5 | 5.35 |
|
P/E
|
29.14 | 74.66 | 29.95 |
|
5yr Avg Cash Conversion Cycle
|
94.46 Days | 76.54 Days | 10.2 Days |
|
5yr Average Interest Coverage Ratio
|
12.05 | 11.52 | 36.33 |
|
5yr Avg ROCE
|
12.13 % | 6.65 % | 37.03 % |
|
5yr Avg Operating Profit Margin
|
15.5 % | 17.76 % | 34.97 % |
|
5 yr average Debt to Equity
|
0.16 | 0.44 | 0.17 |
|
5yr CAGR Net Profit
|
n/a | -27.23 % | 10.17 % |
|
5yr Average Return on Assets
|
6.11 % | 3.1 % | 18.81 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.72 % | 44.23 % | 68.3 % |
|
Share Pledged by Promoters
|
0.01 % | 7.92 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.26 % | -5.78 % | 0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-4.21 % | 3.04 % | -2.44 % |
|
Aarti Pharmalabs
|
Shilpa Medicare
|
Supriya Lifescience
|
|---|